KUMAR AMIT 4
4 · Anixa Biosciences Inc · Filed Jul 31, 2023
Insider Transaction Report
Form 4
KUMAR AMIT
DirectorChief Executive Officer
Transactions
- Exercise/Conversion
Common Stock
2023-07-28$2.58/sh+40,000$103,000→ 502,100 total - Tax Payment
Common Stock
2023-07-28$3.63/sh−28,375$103,001→ 473,725 total - Sale
Common Stock
2023-07-31$3.57/sh−11,800$42,126→ 461,925 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2023-07-28−40,000→ 0 totalExercise: $2.58From: 2013-11-08Exp: 2023-11-08→ Common Stock (40,000 underlying)
Footnotes (2)
- [F1]The reporting persons exercised the stock options at this time due to their expiration on November 8, 2023. The disposal of shares reported herein represents shares withheld by Anixa Biosciences, Inc. (the "registrant") to cover the exercise price of the stock options.
- [F2]Right-To-Buy, pursuant to a stock option grant dated November 8, 2013.